Header Logo

Connection

JENNIFER LEIGH MCQUADE to Neoplasm Invasiveness

Back to Details
This is a "connection" page, showing publications JENNIFER LEIGH MCQUADE has written about Neoplasm Invasiveness.
JENNIFER LEIGH MCQUADE
Connection Strength
0.021
Neoplasm Invasiveness
  1. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.